NCT06032806

Brief Summary

This study aimed to assess the effectiveness of 8 weeks of moderate and high intensity training on hemoglobin levels of female students

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 5, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 13, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2024

Completed
9 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 29, 2024

Completed
Last Updated

March 5, 2024

Status Verified

March 1, 2024

Enrollment Period

6 months

First QC Date

September 5, 2023

Last Update Submit

March 4, 2024

Conditions

Moderate and High Intensity Training and Hemoglobin Levels

Outcome Measures

Primary Outcomes (3)

  • hemoglobin (Hb) level improvement

    Changes from the baseline will be measured The amount of hemoglobin in whole blood is expressed in grams per deciliter (g/dl). The normal Hb level for males is 14 to 18 g/dl; that for females is 12 to 16 g/dl.

    8 weeks

  • CBC (Complete blood count)

    Changes from the baseline will be measured The CBC test identifies and counts the 7 types of cells found in the blood, red blood cell, neutrophil, eosinophil, basophil, lymphocyte, monocyte, and platelet.

    8 weeks

  • Pulse oximeter for Heart Rate

    Pulse oximeters are often used for estimating heart rate at rest and during exercise.

    8 weeks

Study Arms (2)

Group A (Moderate Intensity)

EXPERIMENTAL

Warm up protocol to reach max HR 50% than moderate intensity exercise. Group A will be given moderate intensity exercise i.e Brisk walk (HR will be in between 50-60% of max HR) .

Other: moderate intensity

Group B (High Intensity)

EXPERIMENTAL

Warm up protocol achieve 70% of max HR. Group B will be given high intensity exercise i.e Skipping rope (HR will be in between 70-85% of max HR).

Other: High intensity

Interventions

moderate intensityOTHER

* Arm circles * Leg swings * Lunges

Group A (Moderate Intensity)
High intensityOTHER

* Arm circles * Leg swings * Lunges * Butt kicks

Group B (High Intensity)

Eligibility Criteria

Age23 Years - 27 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age between 18-25 years.
  • Hb levels greater than 10 \& less than 12.0 gm/dl

You may not qualify if:

  • Female staff of the institute.
  • Students already engaged in physical activity.
  • Hb levels greater than 12.0 \& less than 10 gm/dl
  • Female having any bony deformity (spine, hip, knee \& ankle)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sargodha institute of health sciences

Sargodha, Punjab Province, 40100, Pakistan

Location

MeSH Terms

Conditions

Lymphoma, Follicular

Condition Hierarchy (Ancestors)

Lymphoma, Non-HodgkinLymphomaNeoplasms by Histologic TypeNeoplasmsLymphoproliferative DisordersLymphatic DiseasesHemic and Lymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Study Officials

  • Tanzeela Rehman, DPT

    Riphah International University Islamabad

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 5, 2023

First Posted

September 13, 2023

Study Start

August 1, 2023

Primary Completion

January 20, 2024

Study Completion

January 29, 2024

Last Updated

March 5, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations

PA(1)